Advertisement

Document › Details
Wilex AG. (4/24/17). "Press Release: Wilex AG Plans Rights Issue Using Authorised Capital. Ad-hoc release [Not for distribution, publication or transmission in the USA, Canada, Japan and Australia]". Munich.
![]() |
Organisation | Wilex AG |
Today | Heidelberg Pharma AG (FSE: WL6) | |
Group | Heidelberg Pharma (Group) | |
Organisation 2 | Dievini Hopp BioTech Holding GmbH & Co. KG | |
Group | HOPP Group (family of Dietmar Hopp) | |
![]() |
Product | Antibody Targeted Amanitin Conjugate (ATAC) |
Product 2 | investment banking | |
![]() |
Person | Wimmer, Sylvia (Wilex 201403 Corporate Communications) |
Person 2 | Arnold, Katja (MC Services 201309 CIRO Executive Director before Wilex AG + CAT Consultants) | |
Original document
accessed by [iito] on 2017-05-01
Record changed: 2017-05-02 |
Advertisement
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
More documents for Heidelberg Pharma (Group)
- [1] Hofmann, Siegfried / Brors, Peter. (12/5/18). "News: Interview – Dietmar Hopp glaubt an seine Biotechs – »Wir werden unseren Einsatz verdreifachen«"....
- [2] Heidelberg Pharma AG. (3/5/18). "Press Release: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive MultiTarget Research Agreement for the Development of Antibody Drug Conjugates". Ladenburg & Cambridge, MA....
- [3] Heidelberg Pharma AG. (3/1/18). "Press Release: Heidelberg Pharma Signs License Agreement with The University of Texas MD Anderson Cancer Center". Ladenburg....
- [4] Heidelberg Pharma AG. (10/19/17). "Press Release: Wilex AG Successfully Completes Change of Name to Heidelberg Pharma AG". Ladenburg....
- [5] Wilex AG. (10/9/17). "Press Release: Wilex AG Announces Adjustment of Guidance [Ad-hoc release – Insider information pursuant to Article 17 MAR]". Ladenburg....
- [6] Wilex AG. (10/9/17). "Press Release: Interim Management Statement for the First Nine Months of 2017". Munich....
- [7] Wilex AG. (7/13/17). "Press Release: Wilex Reports on First Half-year". Munich....
- [8] Wilex AG. (6/19/17). "Press Release: Wilex Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates". Munich....
- [9] Wilex AG. (4/12/17). "Press Release: Interim Management Statement on the First Three Months of 2017". Munich....
- [10] Wilex AG. (2/6/17). "Press Release: Wilex AG Secures Financing Commitment from Its Main Shareholder Dievini". Munich....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top